Cantor DJ, Nimeiri H, Horn L, West M, et al. Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status-A Real-World Analysis in Patients With Advanced NSCLC. Clin Lung Cancer 2025;26:503-510.
PMID: 40544018